Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants

References

• Price VH. Treatment of hair loss. N Eng J Med 1999;341:964–973.
   PubMed Web of Science ®Google Scholar
• Hamilton JB. Patterned loss of hair in man; types and incidence. Ann NY Acad Sci 1951;53:708–728.
   PubMed Web of Science ®Google Scholar
• Hugo Perez BS. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. Med Hypotheses 2004;62:112–115.
   PubMed Web of Science ®Google Scholar
• Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000:43:768–776.
   PubMed Web of Science ®Google Scholar
• Sinclair RD. Male androgenetic alopecia. J Mens Health Gend 2004;1:319–327.
   Google Scholar
• Sinclair RD. Male androgenetic alopecia (Part II). J Mens Health Gend 2005;2:38–44.
   Google Scholar
• Sovak M, Seligson AL, Kucerova R, Bienova M, Hajduch M, Bucek M. Fluridil, a rationally designed topical agent for androgenetic alopecia: First clinical experience. Dermatol Surg 2002;28:678–685.
   PubMed Web of Science ®Google Scholar
• Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D, Roberts J, Kopera D, Stene JJ, Calvieri S, Tosti A, Prens E, Guarrera M, Kanojia P, He W, Kaufman KD. Finasteride increases anagen hair in men with androgenetic alopecia. Br J Dermatol 2000;143:804–810.
   PubMed Web of Science ®Google Scholar
• Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D, Rapaport M, Kang S, Kelly T, Pariser D, Webster G, Hordinsky M, Rietschel R, Katz HI, Terranella L, Best S, Round E, Waldstreicher J. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999;40:930–937.
   PubMed Web of Science ®Google Scholar
• Price VH, Menefee E, Sanchez M, Ruane P, Kaufman KD. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily. J Am Acad Dermatol 2002;46:517–523.
   PubMed Web of Science ®Google Scholar
• Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39:578–589.
   PubMed Web of Science ®Google Scholar
• Stough DB, Rao NA, Kaufman KD, Mitchell C. Finasteride improves male pattern hair loss in a randomized study in identical twins. Eur J Dermatol 2002;12:32–37.
   PubMed Web of Science ®Google Scholar
• Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006;323:1–10.
   PubMed Web of Science ®Google Scholar
• Kumar R, Singh B, Bakshi G, Katare OP. Development of liposomal systems of Finasteride for topical applications: Design, characterization, and in vitro evaluation. Pharm Dev Technol 2007;12:591–601.
   PubMed Web of Science ®Google Scholar
• Gabrijelcic V, Sentjurc M. Influence of hydrogels on liposome stability and on the transport of liposome entrapped substances into the skin. Int J Pharm 1995;118:207–212.
   Web of Science ®Google Scholar
• Auner BG, Petzenhauser E, Valenta C. Influence of 6-ketocholestanol on skin permeation of 5-aminolevulinic acid and evaluation of chemical stability. J Pharm Sci 2004;93:2780–2787.
   PubMed Web of Science ®Google Scholar
• El Maghraby GMM, Williams AC, Barry BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 2004;276:143–161.
   PubMed Web of Science ®Google Scholar
• Barry BW. Dermatological formulations; percutaneous absorption. New York: Marcel Dekker; 1983:127–233.
   Google Scholar
• Lopez A, Llinares F, Cortell C, Herraez M. Comparative enhancer effects of span 20 with Tween 20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm 2000;202:133–140.
   PubMed Web of Science ®Google Scholar
• Santoyo S, Ygartua P. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. Eur J Pharm Biopharm 2000;50:245–250.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Essential oils as novel human skin penetration enhancers. Int J Pharm 1989;57:7–9.
   Web of Science ®Google Scholar
• Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971;51:702–747.
   PubMed Web of Science ®Google Scholar
• Curdy C, Kalia YN, Naik A, Guy RH. Piroxicam delivery into human stratum corneum in vivo: Iontophoresis versus passive diffusion. J Control Release 2001;11:73–79.
   Google Scholar
• Mura P, Faucci MT, Bramanti G, Corti P. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 2000;9:365–372.
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P. Transdermal delivery of naloxone: Effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 2001;219:95–105.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Barzegar-Jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm 2003;250:359–369.
   PubMed Web of Science ®Google Scholar
• Shokri J, Nokhodchi A, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Barzegar Jalali M. The effect of surfactants on the skin penetration of diazepam. Int J Pharm 2001;228:99–107.
   PubMed Web of Science ®Google Scholar
• Riegelman S, Crowell W. The kinetics of rectal absorption. II. The absorption of anions. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1958;47:123–127.
   Google Scholar
• Riegelman S, Crowell WJ. The kinetics of rectal absorption. I. Preliminary investigations into the absorption rate process. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1958;47:115–122.
   Google Scholar
• Riegelman S, Crowell WJ. The kinetics of rectal absorption. III. The absorption of undissociated molecules. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1958;47:127–133.
   Google Scholar
• Aguiar AJ, Weiner MA. Percutaneous absorption studies of chloramphenicol solutions. J Pharm Sci 1969;58:210–215.
   PubMed Web of Science ®Google Scholar
• Ribaud C, Garson JC, Doucet J, Leveque JL. Organization of stratum corneum lipids in relation to permeability: Influence of sodium lauryl sulfate and preheating. Pharm Res 1994;11:1414–1418.
   PubMed Web of Science ®Google Scholar
• Froebe CL, Simion FA, Rhein LD, Cagan RH, Kligman A. Stratum corneum lipid removal by surfactants: Relation to in vivo irritation. Dermatologica 1990;181:277–283.
   PubMedGoogle Scholar
• Leveque JL, de Rigal J, Saint-Leger D, Billy D. How does sodium lauryl sulfate alter the skin barrier function in man? A multiparametric approach. Skin Pharmacol 1993;6:111–115.
   PubMedGoogle Scholar
• Blank IH, Gould E, Theobald A. Penetration of cationic surfactants into skin. J Invest Dermatol 1964;42:363–366.
   PubMed Web of Science ®Google Scholar
• Borras-Blasco J, Lopez A, Morant MJ, Diez-Sales O, Herraez-Domingues M. Influence of sodium lauryl sulphate on the in vitro percutaneous absorption of compounds with different lipophilicity. Eur J Pharm Sci 1997;5:15–22.
   Web of Science ®Google Scholar
• Cooper ER. Increased skin permeability for lipophilic molecules. J Pharm Sci 1984;73:1153–1156.
   PubMed Web of Science ®Google Scholar